ADMA Biologics Inc (ADMA)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 197,673 | -28,239 | -65,904 | -71,648 | -75,749 |
| Revenue | US$ in thousands | 426,454 | 258,215 | 154,080 | 80,943 | 42,220 |
| Net profit margin | 46.35% | -10.94% | -42.77% | -88.52% | -179.41% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $197,673K ÷ $426,454K
= 46.35%
The net profit margin of ADMA Biologics Inc has displayed significant fluctuations over the period from December 31, 2020, to December 31, 2024. Starting with a negative net profit margin of -179.41% in December 2020, the company improved this metric to -88.52% by the end of 2021. Subsequently, ADMA Biologics Inc continued to enhance its financial performance, achieving a net profit margin of -42.77% by December 2022 and further narrowing the negative margin to -10.94% by the end of 2023.
The most notable shift occurred in December 2024 when ADMA Biologics Inc experienced a significant turnaround, recording a positive net profit margin of 46.35%. This improvement suggests that the company may have implemented strategic initiatives to enhance profitability and operational efficiency.
In conclusion, the trend in ADMA Biologics Inc's net profit margin demonstrates a progressive path from substantial losses to profitability, indicating a potential positive trajectory for the company's financial performance over the analyzed period.
Peer comparison
Dec 31, 2024